AntiVEGF therapy vs Ozurdex for the treatment of Diabetic Macular Edema

Wendell Jones
Diabetic Macular Edema (DME) is the leading cause of vision loss in patients with diabetes due to accumulation of fluid in the retina. The accumulation of fluid in the retina is beleived to be caused by upregulation of VEGF in retina. AntiVEGF therapy is the gold standard for the treatment of DME. Although effective, approximately two thirds of patients treated DME do not respond to antiVEGF therapy and continue to loss vision, suggesting an underlying...

Registration Year

  • 2021

Resource Types

  • Output Management Plan


  • Washington University Medical Center